SYNDEO Medical Introduces Rover SA™ Hemostasis Valve for Interventional Procedures

ZAVENTEM, Belgium — FOR IMMEDIATE RELEASE

19 June 2023 – SYNDEO Medical is pleased to announce the release of Rover SA™, an innovative spring actuated hemostasis valve designed to enhance interventional procedures. This strategic and important addition to our portfolio brings additional choice and advanced performance to interventional healthcare providers worldwide.

The Rover SA™, specifically designed to accept up to 9.5 French devices, offers compatibility with a wide range of interventional procedures. Its innovative spring-actuated mechanism provides precise control and reliable hemostasis, empowering interventional healthcare providers to perform procedures with confidence. Incorporated within the device is a proprietary two-seal mechanism designed to minimize blood loss and maximize performance during use.

"We are excited to introduce the Rover SA™, offering interventional healthcare providers a versatile solution that seamlessly integrates into their procedures," said Justin J. Lampropoulos, CEO of SYNDEO Medical. "With the Rover SA™, healthcare providers now have an additional choice for spring-actuated hemostasis valves in the global marketplace, which we believe is a much-welcome addition."

The Rover SA™ will be available as a standalone device and also included in the SYNDEOPack, our comprehensive interventional procedure pack portfolio.This dual availability provides interventional healthcare providers with flexibility in incorporating the Rover SA™ into their workflows, enabling streamlined procedures and improved overall efficiency.

For more information on the Rover SA™, please contact SYNDEO Medical or visit syndeomedical.be.